SKINCEUTICALS® CELEBRATES

25 Beautiful Years As A Global Pioneer In Skin Health

Taking a closer look at one of the leading integrated skincare brands in the world

FOUNDED IN DALLAS, TX, IN 1997, THE SKINCEUTICALS BRAND OF scientifically-backed treatment products has been at the forefront of integrated skincare. The brand’s history became synonymous with skin science from its inception.

Being the brainchild of the highly revered Dr. Sheldon R. Pinnell, who served as Chief of Dermatology at the prestigious Duke University Medical Center in North Carolina, SkinCeuticals boasts a rich history steeped in science. One of Dr. Pinnell’s milestone discoveries is the Duke Antioxidant patent that has been a driving force for the brand throughout its rich history.

In 2005, L’Oréal acquired SkinCeuticals, the same year that the iconic C E Ferulic took the professional skincare space to the next level. This first-of-its-kind daytime antioxidant featured a synergistic combination of ferulic acid, L-ascorbic acid, and alpha-tocopherol that delivered potent environmental protection while improving the appearance of lines, wrinkles, and discolouration.

The SkinCeuticals philosophy is based on a precise combination of clinical in-office procedures and an advanced homecare regime, the ideal pairing to achieve healthy, youthful-looking skin. True to their rich heritage, the brand formulates skincare with proven efficacy as a safe and effective complement to office-based treatments for reduced downtime and optimal results. Made in the USA, the SkinCeuticals range of clinical skincare is used globally by over 8,000 skincare professionals for daily homecare and complements the results of aesthetic procedures.

contact wl@wendylewisco.com

Science-backed skincare without a prescription

SkinCeuticals’ stated mission has been to improve skin health by providing advanced skincare backed by science from over two decades of research. Made in the USA, the brand’s high potency formulas have been proven to be absorbed optimally into the skin. Their complete skincare solutions are recommended by dermatologists, plastic surgeons, medispas, and other skin care professionals worldwide to correct the appearance of the signs of ageing and help prevent future damage.

Today, after 25 years, the SkinCeuticals mantra has remained consistent; to improve skin health through advanced skincare, backed by science, research, and innovation. Centred around three main pillars: Prevent, Correct and Protect, to deliver healthy skin and optimal results.

Their comprehensive range of advanced products works synergistically to provide effective results that resonate with dermatologists, plastic surgeons, and aesthetic doctors worldwide. Targeting an extensive range of skin issues such as pigmentation (hormone and sun damage), collagen, vascular, and environmental damage, among others, the SkinCeuticals portfolio features highly effective formulations. Their C E Ferulic, Phloretin CF, Silymarin CF, H.A. Intensifier and Phyto Corrective are their most popular products.

According to Dr. Ana Mansouri, Aesthetic Doctor at Kat & Co, in Birmingham, UK, ‘I am a firm advocate for the value of early integration of medical-grade skincare, particularly with my injectable cases. This is due to experiencing how this has transformed my practice, both from a business point of view, and by enhancing clinical outcomes.’

Integrating skincare into the patient’s treatment journey

An integral component of the SkinCeuticals philosophy is achieving long-lasting comprehensive results through a winning combination of state-of-the-art clinical protocols, professional treatments, and advanced homecare.

The brand’s signature ‘Integrated Skincare’ concept was developed around clinical procedures, offering home care for pre-conditioning, post-treatment, and carrying it through to daily use. This premise of integrated results stands apart as an effective and comprehensive protocol to optimize aesthetic outcomes for patients. The overall benefits this system delivers are long-lasting visible results and healthier, more youthful-looking skin over time.

‘My approach to SkinCeuticals integrated skincare is based around a simple ‘ABC + targeted treatment’ routine where I utilise vitamin A, sunblock and vitamin C to prepare my patients’ skin for any rejuvenating treatments. This is carried out for 4-8 weeks pre-procedure, as well as for ongoing maintenance of results by optimising neocollagenesis in the longer term,’ says Dr. Mansouri. ‘I also recommend adding targeted HA serums and ceramide-based moisturisers to support the maintenance process post-injectables in dry and mature skin types. My recommended product combination is the H.A. Intensifier, as this has been shown to improve HA levels by up to 30% in just four weeks, paired with the Triple Lipid Restore 2:4:2 to support the barrier function of the skin,’ she says.

As leaders in antioxidant and sun protection technology, SkinCeuticals products have been shown to

Pioneering Partnerships

In 2021, the brand formed an innovative commercial partnership with aesthetic technology manufacturer Cutera. Focused on the UK aesthetics market, this collaboration aims for both brands to work together to develop a specialist treatment protocol that will help optimise

Skinceuticals Research

C E Ferulic & Laser Treatments

C E Ferulic is a patented triple antioxidant serum that fights environmental aggressors caused by UV, IR-A, and pollution. When used in combination with laser treatments, it is clinically proven to complement results and reduce downtime post non-ablative laser and accelerate recovery post fractional ablative laser. Patients saw an overall satisfaction in firmness, radiance, and overall appearance, as well as decreased downtime1

Triple Lipid Restore

2:4:2 & Retinoids

Triple Lipid Restore is an advanced corrective moisturiser that improves skin firmness, laxity, pore appearance, and refined texture for a more radiant complexion. When used in combination with retinoids, it is clinically proven to significantly improve dryness and shorten the retinoid adjustment period to 1 week. It also improves the tolerance of tretinoin therapy in retinoid averse patients2 clinical outcomes for patients. Through select workshops for customers in the UK, they have introduced the newly developed protocol to evaluate the clinical outcomes that result from this unique combination.

Sam Keene, Senior Marketing Manager for Cutera in Europe, explains, ‘We were very pleased to form this important partnership with SkinCeuticals. We feel that both brands complement each other extremely well, with our shared goals for innovation in the aesthetics market, as well as our commitment to providing results-driven treatments based on extensive research. We are currently finalizing a clinical evaluation in partnership with Cosmetic Doctor Julia Sevi in Leeds. We look forward to publishing the results of this trial. From what we have seen so far, it is very exciting.’